CHICAGO, Aug. 8, 2017 /PRNewswire/ -- Groove Health, the Chicago-based digital health company,
Groove Health's proprietary analytics platform combines existing healthcare data with patient-generated data from Groove's mobile app and other sources to create a 360-degree understanding of each patient's unique adherence profile. Groove then implements its patient engagement program, which leverages a mobile app and other forms of outreach, to influence health-positive behaviors in high-risk patients. The combined end-to-end platform integrates directly into the enterprise workflow, improves the efficiency of existing care teams, and provides organizations with new methods of engaging patients.
"The complex nature of medication adherence demands solutions that are more innovative than simple medication reminders," said Hourani. "Health literacy, financial concerns, social issues, and other factors often influence non-adherent behavior. We are helping our enterprise customers identify and address these issues on an individualized basis."
Each year in the U.S., poor medication adherence causes 30-50% of treatment failures, 125,000 deaths, and over $100 billion of avoidable healthcare spending. A recent study found that 26% of hospital readmissions were potentially preventable and medication-related.1 The Centers for Medicare & Medicaid Services ("CMS") and the National Committee for Quality Assurance ("NCQA") incorporate medication adherence measures in their Star Ratings programs, which measure health plans' performance on important dimensions of care and service.
ABOUT GROOVE HEALTH:
Founded in 2016 and based in Chicago, Illinois, Groove Health is a digital health company focused on improving medication adherence in chronically-ill populations. Groove is committed to improving the lives of patients managing a chronic illness. Learn more at www.groovehealthrx.com.
1 Pellegrin et al, Potentially Preventable Medication-Related Hospitalizations, Journal of the American Pharmacists Association (2017), doi: 10.1016/ j.japh.2017.06.019.
View original content:http://www.prnewswire.com/news-releases/groove-health-raises-16-million-for-its-data-driven-medication-adherence-platform-300500901.html
SOURCE Groove Health
Subscribe to our Free Newsletters!
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...View All